Related Experiment Videos

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes

L P Choo-Smith1, W K Surewicz

  • 1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

FEBS Letters
|February 3, 1997
PubMed

Insights

Alzheimer amyloid peptide A beta(1-40) binds specifically to ganglioside GM1 membranes, transitioning to a beta-sheet structure. This interaction may alter the peptide's neurotoxic and amyloidogenic properties.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Alzheimer's disease is linked to amyloid peptide A beta(1-40) aggregation.
  • Understanding A beta(1-40) interactions with cell membranes is crucial for Alzheimer's research.

Purpose of the Study:

  • To investigate the interaction between Alzheimer amyloid peptide A beta(1-40) and membrane lipids.
  • To determine the conformational changes of A beta(1-40) upon binding to specific lipids.

Main Methods:

  • Circular dichroism spectroscopy was used to study peptide-lipid interactions.
  • Experiments were conducted at physiologically relevant ionic strength and neutral pH.

Main Results:

  • A beta(1-40) binds to membranes containing ganglioside GM1.
  • Upon binding, A beta(1-40) undergoes a conformational transition from random coil to a beta-sheet-rich structure.
  • This interaction is ganglioside-specific; no conformational changes were observed with phospholipids or sphingomyelin.

Conclusions:

  • Ganglioside GM1 specifically induces a conformational change in A beta(1-40).
  • The isolated oligosaccharide moiety of ganglioside GM1 did not affect A beta(1-40) conformation.
  • Binding to ganglioside GM1 may modulate the neurotoxic and amyloidogenic properties of A beta(1-40).

Related Concept Videos